María Cristina Martínez-Avila

Dr. María Cristina Martínez-Avila

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Jorge Rico FontalvoJorge Rico Fontalvo
Jorge Rico Fontalvo
GAGustavo Aroca
Gustavo Aroca
JCJose Cabrales
Jose Cabrales
RDRodrigo Daza-Arnedo
Rodrigo Daza-Arnedo
TYTomas Rodriguez Yanez
Tomas Rodriguez Yanez
MRMaria Raad
Maria Raad
The inflammatory component of diabetic kidney disease has become of great interest in recent years, with genetic and epigenetic variants playing a fundamental role in the initiation and progression of the disease. Cells of the innate immune system play a major role in the pathogenesis of diabetic kidney disease, with a lesser contribution from the adaptive immune cells. Other components such as the complement system also play a role, as well as specific cytokines and chemokines. The inflammatory component of diabetic kidney disease is of great interest and is an active research field, with the hope to find potential innovative therapeutic targets.

1 January 2022 in Women's Health
Verified
Journal Article
Open access
LQLuisa Rodríguez Quejada
Luisa Rodríguez Quejada
MWMaría Fernanda Toro Wills
María Fernanda Toro Wills
MMMaría Cristina Martínez-Avila
María Cristina Martínez-Avila
APAndrés Felipe Patiño-Aldana
Andrés Felipe Patiño-Aldana
Introduction: After COVID-19 vaccination, women of reproductive age reported changes in their menstrual cycle. Materials and methods: A retrospective study was carried out after a survey on social networks that included women aged 18–41 years with normal cycles according to International Federation of Gynecology and Obstetrics and who were vaccinated (complete schedule for two doses, except J&J/Janssen or incomplete with a single dose). Women with following conditions were excluded: pregnant or lactating women; history of diseases that cause menstrual irregularities or early menopause: anorexia, bulimia, polycystic ovary syndrome, hypothyroidism, obesity, or low weight; hysterectomized or oophorectomized patients; and high performance athletes. Results: Overall, 950 women completed the survey between July and September 2021. In total, 408 women met the inclusion criteria, and 184 reported the following characteristics: frequency (normal 43.47%, infrequent 25%, and frequent 31.53%), regularity (regular 51.08%, irregular 42.93%, and absent/amenorrhea 5.97%), duration (normal 65.21%, prolonged 26.08%, absent/amenorrhea 8.69%), and volume (heavy 41.84%, light 20.65%, and absent/amenorrhea 6.52%). Conclusions: SARS-CoV-2 infection and COVID-19 vaccination can influence the menstrual cycle and cause alterations.

23 September 2022 in International Journal Of Clinical Practice
Verified
Journal Article
Open access
PDF file
AAAmilkar Almanza-Hurtado
Amilkar Almanza-Hurtado
CGCamilo Polanco Guerra
Camilo Polanco Guerra
MMMaría Cristina Martínez-Avila
María Cristina Martínez-Avila
DBDiana Borré-Naranjo
Diana Borré-Naranjo
TRTomás Rodríguez-Yanez
Tomás Rodríguez-Yanez
CDCarmelo Dueñas-Castell
Carmelo Dueñas-Castell
Acute hypercapnic ventilatory failure is becoming more frequent in critically ill patients. Hypercapnia is the elevation in the partial pressure of carbon dioxide (PaCO2) above 45 mmHg in the bloodstream. The pathophysiological mechanisms of hypercapnia include the decrease in minute volume, an increase in dead space, or an increase in carbon dioxide (CO2) production per sec. They generate a compromise at the cardiovascular, cerebral, metabolic, and respiratory levels with a high burden of morbidity and mortality. It is essential to know the triggers to provide therapy directed at the primary cause and avoid possible complications.

2 August 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
AHAbraham Hernández-Blanquisett
Abraham Hernández-Blanquisett
VQValeria Quintero-Carreño
Valeria Quintero-Carreño
AÁAngelina Álvarez-Londoño
Angelina Álvarez-Londoño
MMMaría Cristina Martínez-Avila
María Cristina Martínez-Avila
RDRaissa Diaz-Cáceres
Raissa Diaz-Cáceres
The increasing number of breast cancer survivors has led to a greater emphasis on issues related to quality of life (QoL). Up to 75% of women treated for breast cancer (BC) report sexual disorders. However, most oncologists are not trained to recognize which patients are at high-risk of developing sexual disorders. Female sexual dysfunction (FSD) is common in patients with BC; we found that patients without FSD prior to BC treatment are at risk of developing FSD after treatment. Treatment of early BC relies on the combination of chemotherapy, surgery, and radiation therapy. All these treatments have side effects or sequelae identified as high-risk factors for the development of FSD. The choice of less toxic treatments in each modality could reduce the risk of FSD in some cases, without affecting the risk of recurrence or effectiveness. A comprehensive approach of BC must consider FSD as a determinant factor of QoL in survivors.

29 September 2022 in Journal of International Medical Research
Verified
Journal Article
Open access
TRTomás Rodríguez-Yanez
Tomás Rodríguez-Yanez
JRJesús Daniel Rodríguez-Blanco
Jesús Daniel Rodríguez-Blanco
AAAmilkar José Almanza-Hurtado
Amilkar José Almanza-Hurtado
MMMaría Cristina Martínez-Avila
María Cristina Martínez-Avila
DBDiana Borré-Naranjo
Diana Borré-Naranjo
CDCarmelo Dueñas-Castell
Carmelo Dueñas-Castell
Neuromuscular blocking agents (NMBA) are a controversial therapeutic option in the approach to the critically ill patient. They are not innocuous, and the available evidence does not support their routine use in the intensive care unit. If necessary, monitoring protocols should be established to avoid residual relaxation, adverse effects, and associated complications. This narrative review discusses the current indications for the use of NMBA and the different tools for monitoring blockade in the intensive care unit. However, expanding the use of NMBA in critical settings merits the development of prospective studies.

15 May 2022 in Tropical Diseases, Travel Medicine and Vaccines
Verified
Journal Article
Open access
PDF file
TATomás Acosta-Pérez
Tomás Acosta-Pérez
TRTomás Rodríguez-Yánez
Tomás Rodríguez-Yánez
AAAmilkar Almanza-Hurtado
Amilkar Almanza-Hurtado
MMMaría Cristina Martínez-Avila
María Cristina Martínez-Avila
CDCarmelo Dueñas-Castell
Carmelo Dueñas-Castell
Since the COVID-19 outbreak, millions of people have been infected with SARS-CoV-2 around the world. An area of epidemiological relevance is Latin America, tropical regions, due to the distribution of endemic diseases such as chikungunya, dengue (DENV), malaria, Zika virus, where febrile disease abounds. The early signs and symptoms of DENV and COVID-19 could be similar, making it a risk that patients may be wrongly diagnosed early during the disease. The problem increases since COVID-19 infection can lead to false positives in DENV screening tests. We present two cases of acute undifferentiated febrile syndrome that were diagnosed with SARS-CoV-2 and DENV co-infection, confirmed by ELISA and RT-PCR for both viral pathogens. The occurrence of simultaneous or overlapped infections can alter the usual clinical course, severity, or outcome of each infection. Therefore, epidemiological surveillance and intensified preparation for those scenarios must be considered, as well as further studies should be done to address cases of co-infection promptly to avoid major complications and fatal outcomes during the current pandemic. Other endemic tropical diseases should not be neglected.